Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00015 USD | -25.00% | +100.00% | 0.00% |
Mar. 25 | BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study | CI |
Feb. 23 | Bioelectronics Corporation Announces the Publication of Pilot Study Results | CI |
Financials (USD)
Sales 2020 | 830K | Sales 2021 | 1.61M | Capitalization | 25.6M |
---|---|---|---|---|---|
Net income 2020 | -1M | Net income 2021 | - | EV / Sales 2020 | 53.6 x |
Net Debt 2020 | 13.07M | Net Debt 2021 | 13.34M | EV / Sales 2021 | 24.2 x |
P/E ratio 2020 |
-26.5
x | P/E ratio 2021 |
-95.5
x | Employees | 9 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
1 day | -25.00% | ||
1 week | +100.00% | ||
Current month | -33.33% | ||
1 month | -33.33% | ||
6 months | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Kelly A. Whelan
CEO | Chief Executive Officer | - | 19-11-14 |
Keith E. Nalepka
SAM | Sales & Marketing | - | 17-08-31 |
John M. Martinez
PRN | Corporate Officer/Principal | - | 02-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 83 | 20-06-14 | |
Keith E. Nalepka
SAM | Sales & Marketing | - | 17-08-31 |
Kelly A. Whelan
CEO | Chief Executive Officer | - | 19-11-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.00015 | -25.00% | 28,245,000 |
24-04-25 | 0.0002 | 0.00% | 7,306,938 |
24-04-24 | 0.0002 | +33.33% | 56,127,000 |
24-04-23 | 0.00015 | -25.00% | 285,678,650 |
24-04-22 | 0.0002 | +100.00% | 3,107,506 |
Delayed Quote OTC Markets, April 26, 2024 at 03:39 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 3.71M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- BIEL Stock